Addition of androgen deprivation therapy to PBRT halts progression of prostate cancer: Lancet Medical Dialogues Editorial Team24 May 2022 9:30 AM ISTA new study published in The Lancet shows the advantage of combining short-term androgen deprivation treatment (ADT) with prostate bed radiation...
Androgen deprivation therapy in men with prostate cancer reduces risk of thyroid diseases: Study Medha Baranwal18 April 2022 9:00 AM ISTTaiwan: The use of androgen deprivation therapy (ADT) in men with metastatic prostate cancer (PCa) is tied to a reduced risk of thyroid disease...
DXA Scan Can Prevent Major Fractures among Prostate Cancer patients on ADT MD Bureau11 April 2022 9:00 AM ISTProstate cancer accounts for 26% of all new cancers in men. Androgen deprivation therapy (ADT) is the mainstay for the treatment of locally advanced...
Local ablative radiation may delay disease progression in oligometastatic prostate cancer patients: Study MD Editorial Team10 Dec 2021 9:00 AM ISTGermany: Local ablative radiation (aRT) for oligometastatic prostate cancer (PCa) has shown great promise and has been a focus of current clinical...
Cumulative Androgen Deprivation Therapy paves way to higher risk of Dementia MD Editorial Team9 Dec 2021 9:15 AM ISTThe link between androgen deprivation therapy (ADT) and dementia in men with prostate cancer is still unclear. Researchers have found in a new study...
Does ADT help reduce mortality among patients with Prostate Cancer and COVID-19? MD Editorial Team15 Nov 2021 7:15 PM ISTAndrogen deprivation therapy (ADT) has been theorized to decrease the severity of SARS-CoV-2 infection in patients with prostate cancer owing to a...
Enzalutamide plus ADT effective in Metastatic Prostate Cancer, Finds study Dr. Nandita Mohan24 Jan 2021 11:30 PM ISTResearchers from the Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, North Carolina have recently noted that treatment with...
Statins improve survival in prostate cancer treated with ADT, finds study Dr. Nandita Mohan12 Jan 2021 4:15 PM ISTAccording to recent research, it have been shown that in men treated with ADT following primary or salvage radiotherapy, statin use was associated...
FDA Approves first Oral Hormone Therapy for Treating Advanced Prostate Cancer Hina Zahid20 Dec 2020 8:43 PM ISTThe FDA has approved relugolix an oral androgen deprivation therapy ADT for men with advanced prostate cancer. The FDA granted approval of Orgovyx to...
Enzalutamide may improve survival in high risk Castration-resistant prostate cancer Hina Zahid21 Aug 2020 9:30 AM ISTIn 2018 and 2019, the German Institute for Quality and Efficiency in Health Care (IQWiG) already investigated whether the drug enzalutamide has an...
Darolutamide has considerable added benefit in prostate cancer: Study Hina Zahid4 Aug 2020 12:15 PM ISTUp to now, adult men with non-metastatic castration-resistant prostate cancer (nmCRPC) at high risk of developing metastatic disease usually continued...
Acute exercise may boost up immune system during prostate cancer: Study Hina Zahid31 July 2020 7:30 PM ISTNew research published this week in Experimental Physiology found that in prostate cancer survivors, a moderate bout of exercise kept the cell count...
